If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?
出版年份 2022 全文链接
标题
If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?
作者
关键词
-
出版物
PLOS BIOLOGY
Volume 20, Issue 7, Pages e3001694
出版商
Public Library of Science (PLoS)
发表日期
2022-07-22
DOI
10.1371/journal.pbio.3001694
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics
- (2022) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Cryo-EM structures of amyloid-β 42 filaments from human brains
- (2022) Yang Yang et al. SCIENCE
- Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
- (2022) Emma Nichols et al. Lancet Public Health
- Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study
- (2022) Estrella Morenas-Rodríguez et al. LANCET NEUROLOGY
- Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology
- (2021) Seung-Hye Lee et al. NEURON
- Alzheimer’s-causing mutations shift Aβ length by destabilizing γ-secretase-Aβn interactions
- (2021) Maria Szaruga et al. CELL
- The PrecivityAD™ Test: Accurate and Reliable LC-MS/MS Assays for Quantifying Plasma Amyloid Beta 40 and 42 and Apolipoprotein E Proteotype for the Assessment of Brain Amyloidosis
- (2021) Kristopher M. Kirmess et al. CLINICA CHIMICA ACTA
- Microglia use TAM receptors to detect and engulf amyloid β plaques
- (2021) Youtong Huang et al. NATURE IMMUNOLOGY
- A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
- (2021) Chad J. Swanson et al. Alzheimers Research & Therapy
- A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
- (2021) Stephen Salloway et al. NATURE MEDICINE
- CSF p-tau increase in response to Aβ-type and Danish-type cerebral amyloidosis and in the absence of neurofibrillary tangles
- (2021) Stephan A. Kaeser et al. ACTA NEUROPATHOLOGICA
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer’s Disease
- (2020) Joseph W. Lewcock et al. NEURON
- Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life
- (2020) Ruth E. Uhlmann et al. NATURE NEUROSCIENCE
- Plasma N-terminal tau fragment levels predict future cognitive decline and neurodegeneration in healthy elderly individuals
- (2020) Jasmeer P. Chhatwal et al. Nature Communications
- Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer’s disease
- (2019) Michael Ewers et al. Science Translational Medicine
- PET imaging of tau protein targets: a methodology perspective
- (2018) Cristina Lois et al. Brain Imaging and Behavior
- Molecular basis for the loss-of-function effects of the Alzheimer’s disease–associated R47H variant of the immune receptor TREM2
- (2018) Athena Sudom et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer’s disease
- (2018) Paul J. Cheng-Hathaway et al. Molecular Neurodegeneration
- An in vitro paradigm to assess potential anti-Aβ antibodies for Alzheimer’s disease
- (2018) Ming Jin et al. Nature Communications
- Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE
- (2018) Samira Parhizkar et al. NATURE NEUROSCIENCE
- The Cellular Phase of Alzheimer’s Disease
- (2016) Bart De Strooper et al. CELL
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
- (2016) Yaming Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid -Protein Oligomers
- (2016) H. Xu et al. JOURNAL OF NEUROSCIENCE
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
- (2016) Mehtap Bacioglu et al. NEURON
- Early changes in CSF sTREM2 in dominantly inherited Alzheimers disease occur after amyloid deposition and neuronal injury
- (2016) M. Suarez-Calvet et al. Science Translational Medicine
- Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology
- (2015) Elizabeth Head et al. Current Alzheimer Research
- Systematic analysis of time-dependent neural effects of soluble amyloid β oligomers in culture and in vivo: Prevention by scyllo-inositol
- (2015) Ming Jin et al. NEUROBIOLOGY OF DISEASE
- Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
- (2014) Jason D Ulrich et al. Molecular Neurodegeneration
- Single App knock-in mouse models of Alzheimer's disease
- (2014) Takashi Saito et al. NATURE NEUROSCIENCE
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis
- (2012) Jungsu Kim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
- (2012) Thorlakur Jonsson et al. NATURE
- Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population
- (2012) Mia Kero et al. NEUROBIOLOGY OF AGING
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Variant of TREM2 Associated with the Risk of Alzheimer's Disease
- (2012) Thorlakur Jonsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- TREM2 Variants in Alzheimer's Disease
- (2012) Rita Guerreiro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders
- (2011) Mathias Jucker et al. ANNALS OF NEUROLOGY
- Soluble amyloid -protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
- (2011) M. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human apoE Isoforms Differentially Regulate Brain Amyloid- Peptide Clearance
- (2011) J. M. Castellano et al. Science Translational Medicine
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now